The Open Payments Data Correction Period Began May 16, 2020, and Will End on May 30, 2020

May 20, 2020

Reminder: Open Payments Review and Dispute Period for Physicians and Teaching Hospitals Will End on May 15, 2020

May 13, 2020

REMINDER: Manufacturers and Wholesalers That Sell or Market Products in Nevada Must Submit Certification and Compliance Forms to the Nevada Board of Pharmacy by June 1, 2020

May 07, 2020

Massachusetts Department of Public Health Launches Pharmaceutical Code Of Conduct – Data and Reports Webpage; Annual Disclosure Reports Due July 1, 2020

May 06, 2020

Certain Pharmaceutical Sales Representatives Are Required to Obtain a License Prior to Conducting Business in Chicago, Illinois

May 05, 2020

The District of Columbia Department of Health has Posted the 2019 Prescription Drug Marketing Cost Reporting Form on Its Website; Reports are Due July 1, 2020

April 28, 2020

Applicable Manufacturers Must Submit Their Reports of Payments or Other Transfers of Value to APRNs Engaged in Independent Practice in Connecticut by July 1, 2020

April 22, 2020

Registered Lobbyists in Miami-Dade County, Florida Must Submit Their Annual Lobbyist Expenditure Report to the Board of County Commissioners by July 1, 2020

April 21, 2020

California Requires Pharmaceutical and Medical Device Manufacturers to Annually Declare Compliance with Their Comprehensive Compliance Program

April 20, 2020

Manufacturers and Wholesalers That Sell or Market Products in Nevada Must Submit Certification and Compliance Forms to the Nevada Board of Pharmacy by June 1, 2020

April 16, 2020

CMS Open Payments Annual Report to Congress for Program Year 2018 Shows Increase in Total Dollar Value of Reported Payments

April 14, 2020

The Open Payments Review and Dispute Period for Physicians and Teaching Hospitals is April 1, 2020, Through May 15, 2020

April 06, 2020

REMINDER - The Centers for Medicare and Medicaid Services Will Host an Open Payments Q&A Session Tomorrow, Thursday, March 26, 2020

March 25, 2020

Maine Adopts Regulations to Implement Prohibition on Gifts to Practitioners; Modest Meals, Reasonable Honoraria are Defined

March 23, 2020

Utah Has Introduced Legislation Requiring Manufacturers to Provide a List of Pharmaceutical Sales Representatives; Establishes Reporting and Price Disclosure Requirements

March 19, 2020

Prescription Drug, Biological Product, and Medical Device Manufacturers Must Submit Their Disclosure Reports to the Vermont Attorney General's Office by April 1, 2020; 2019 Guide to Disclosure Law is Available

March 16, 2020

The Centers for Medicare and Medicaid Services Has Posted Updated Quick Reference Guides and Overview for the 2019 Program Year

March 12, 2020

The Centers for Medicare and Medicaid Services Will Host an Open Payments Q&A Session on Thursday, March 26, 2020

March 05, 2020

The Minnesota Board of Pharmacy Has Posted the 2019 Payments to Practitioners Reporting Form; Reports are Due May 1, 2020

March 02, 2020

Nevada Department of Health and Human Services Has Published the 2020 Essential Drug List; Manufacturer Reports are Due April 1, 2020

February 28, 2020

Federal Drug Samples Disclosure Reports for Calendar Year 2019 Are Due April 1, 2020; Companies Must Have FDA Electronic Submissions Gateway Account to Submit

February 19, 2020

Federal Sunshine Payments Eligible for Delayed Publication Must Have the Delay Indicator Renewed in Each Applicable Program Year

February 14, 2020

Nevada Department of Health and Human Services Will Accept Pharmaceutical Representative Annual Disclosure Reports on Monday, March 2, 2020

February 13, 2020

The Centers for Medicare and Medicaid Services Will Hold Open Payments Webinar Session on February 18, 2020

February 10, 2020

CMS Announces That Applicable Manufacturers and GPOs May Begin Data Submission for Payments or Transfers of Value That Occurred in the 2019 Calendar Year; Entities Must Register or Recertify Registration

February 06, 2020

French Sunshine Act Reporting Deadline Approaching

February 04, 2020

Hawaii Introduces Legislation to Require Pharmaceutical Representatives to Register; Disclose Certain Activities; Abide by Ethical Standards

February 03, 2020

The Centers for Medicare and Medicaid Services Has Published an Open Payments Data Refresh

January 27, 2020

REMINDER: Prescription Drug Manufacturers Must Submit Their Annual Nevada Sales Representative List by January 15, 2020

January 02, 2020

REMINDER – Miami-Dade County, Florida Lobbyists Must Renew Their Annual Lobbyist Registrations by January 15, 2020

December 31, 2019

CMS Announces that the Open Payments System Will Undergo Scheduled System Upgrades; Posts 2019 Data Submission Resources

December 11, 2019

Reminder: Vermont 2019 Compliance Officer Form and Annual Registration Fee Must be Submitted by January 1, 2020

December 05, 2019

Miami-Dade County, Florida Lobbyists Must Renew Their Annual Lobbyist Registrations by January 15, 2020; Online Registration is Open

December 04, 2019

The Department of Health Human Services Has Published Revised Civil Monetary Penalties

November 26, 2019

Centers for Medicare and Medicaid Services Has Issued Final Rule to Implement SUPPORT ACT

November 25, 2019

Pharmaceutical Manufacturers Must Submit Their Annual Nevada Sales Representative List by January 15, 2020

November 22, 2019

Louisiana Lobbyists Must Renew Their Registration Between December 1, 2019 and January 31, 2020

November 19, 2019

The Centers for Medicare and Medicaid Services Will Publish a Refresh of Open Payments Data in January 2020

November 14, 2019

Vermont 2019 Compliance Officer Form is Available; Due January 1, 2020

November 04, 2019

Nevada Department of Health and Human Services Has Clarified Manufacturer Registration Requirements

October 23, 2019

The Centers for Medicare and Medicaid Services Has Posted The Open Payments 2019 Program Year Enhancements

October 14, 2019

CMS Has Posted On Its Open Payments Website The 2020 List Of Teaching Hospitals

October 08, 2019

The Centers for Medicare and Medicaid Services Has Posted on Its Open Payments Website the Adjusted 2020 Reporting Threshold for Payments or Other Transfers of Value

September 26, 2019

The Centers for Medicare and Medicaid Services Has Posted Updated User Guide for Reporting Entities and Quick Reference Guides for the 2019 Program Year

September 17, 2019

Nevada Department of Health and Human Services Has Published its Final Pharmaceutical Sales Representative Compensation & Samples Reporting Instructions and Template

September 12, 2019

Reminder: Comment Period for Centers for Medicare and Medicaid Services Proposed Expanded Reporting Rules for Open Payments Program Closes September 27, 2019

September 09, 2019

Reminder: Pharmaceutical and Medical Device Manufacturers Must Renew Registration with the Massachusetts Department of Public Health by August 31, 2019

August 28, 2019

Vermont Attorney General's Office Has Posted the 2019 Compliance Officer Form, Which is Due January 1, 2020

August 23, 2019

United States Government Files Civil Healthcare Fraud Lawsuit Against Pharmaceutical Company Life Spine, Inc.

August 21, 2019

French Sunshine Act Report Due September 1, 2019

August 13, 2019

Nevada Department of Health and Human Services Has Posted Draft Revised Drug Price Transparency Templates and Instructions for Manufacturers of Essential Drugs

August 09, 2019

Nevada Department of Health and Human Services Has Posted Draft Revised Pharmaceutical Sales Representative Registration and Reporting Templates and Instructions

August 08, 2019

Centers for Medicare and Medicaid Services Proposes Expanded Reporting Rules for Open Payments Program

August 06, 2019

Reminder: Pharmaceutical and Medical Device Manufacturers Must Renew Registration with the Massachusetts Department of Public Health by August 31, 2019

August 05, 2019

Centers for Medicaid and Medicare Services Posts Drug Name and National Drug Code Reference Data to Assist Reporting Entities When Submitting Open Payments Records

July 25, 2019

The Centers for Medicare and Medicaid Services Has Published Program Year 2018 Open Payments Data

July 08, 2019

Pharmaceutical and Medical Device Manufacturers Must Renew Registration With the Massachusetts Department of Public Health by August 31, 2019

July 02, 2019

Prescription Drug Manufacturers and Labelers That Market in the District of Columbia Must Submit Their Annual Prescription Drug Marketing Costs Report by July 1, 2019

June 13, 2019

Registered Lobbyists in Miami-Dade County, Florida Must Submit Their Annual Lobbyist Expenditure Report to the Board of County Commissioners by July 1, 2019

June 10, 2019

Nevada Department of Health and Human Services Issues 2019 Drug Transparency Report; Will Contact Non-Compliant Organizations

June 05, 2019

Reminder: The Open Payments Data Correction Period Will End Tomorrow, May 30, 2019

May 29, 2019

Pharmaceutical and Medical Device Manufacturers Must Submit Annual Disclosure Reports to the Massachusetts Department of Public Health by July 1, 2019

May 23, 2019

Manufacturers and Wholesalers Who Sell or Market Products in Nevada Must Submit Certification and Compliance Forms to the Nevada Board of Pharmacy by June 1, 2019

May 21, 2019

The Open Payments Data Correction Period Began May 16, 2019, and Will End on May 30, 2019

May 17, 2019

Massachusetts Has Changed Its Reporting Form for 2018 Disclosure Reports Due July 1

May 14, 2019

The New Jersey Attorney General Has Adopted Proposed Amendments to Gift Ban Regulation, With Changes

May 08, 2019

Applicable Manufacturers Must Submit Their Reports of Payments or Other Transfers of Value to APRNs Engaged in Independent Practice in Connecticut by July 1, 2019

May 06, 2019

The District of Columbia Department of Health has Posted on Its Website the 2018 Prescription Drug Marketing Cost Reporting Form

May 01, 2019

California Requires Pharmaceutical and Medical Device Companies to Annually Declare Compliance with Their Comprehensive Compliance Program

April 23, 2019

Data Capture for Expanded List of Federal Covered Recipients Will Begin in Calendar Year 2021 for reporting in 2022

April 18, 2019

U.S. House of Representatives Has Introduced Legislation Amending Sunshine Act to Require Reporting of Medical Supply Samples

April 17, 2019

CMS Open Payments Annual Report to Congress for Program Year 2017 Shows Slight Decrease in Total Dollar Value of Reported Payments

April 10, 2019

Maine Board of Pharmacy Proposes Regulations to Define Modest Meals, Reasonable Honoraria for Implementing Prohibition on Gifts to Practitioners

April 09, 2019

Manufacturers and Wholesalers That Sell or Market Products in Nevada Must Submit Certification and Compliance Forms to the Nevada Board of Pharmacy by June 1, 2019

April 05, 2019

The Centers for Medicare and Medicaid Services Has Rescheduled Its Q&A Session to Wednesday, April 10, 2019

April 04, 2019

Drug Manufacturers Must Submit Annual Disclosure Reports to the Minnesota Board of Pharmacy by May 1, 2019

April 03, 2019

CMS Has Announced That the Review and Dispute Period for Physicians and Teaching Hospitals is April 1, 2019, Through May 15, 2019

April 01, 2019

The Centers for Medicare and Medicaid Services Will Hold Its Next Q&A Session on Wednesday, March 27, 2019

March 20, 2019

Federal Sunshine Payments Eligible for Delayed Publication Must Have the Delay Indicator Renewed in Each Applicable Program Year

March 13, 2019

Reporting Entities Registered in Open Payments Must Recertify Before Submitting Data for Upcoming Reporting Period

March 12, 2019

Applicable Manufacturers and GPOs Must Submit Their 2018 Sunshine Act Data in CMS' Open Payments System by March 31, 2019

March 07, 2019

Federal Drug Samples Disclosure Reports for Calendar Year 2018 Are Due April 1, 2019; Companies Must Have FDA Electronic Submissions Gateway Account to Submit

February 25, 2019

The U.S. Supreme Court Denies Maryland's Petition Requesting Review of Fourth Circuit Opinion Striking Down Drug Price Gouging Law

February 22, 2019

Prescription Drug, Biological Product, and Medical Device Manufacturers Must Submit Their Disclosure Reports to the Vermont Attorney General's Office by April 1, 2019; 2018 Guide to Disclosure Law is Available

February 21, 2019

Nevada Pharmaceutical Representative Annual Disclosure Reports Due 3/1/2019

February 14, 2019

Philadelphia City Council Votes to Defeat Proposed Ordinance Regulating Pharmaceutical Representative Sales and Marketing Activity

February 08, 2019

CMS Announces That Applicable Manufacturers and GPOs May Begin Data Submission for Payments or Transfers of Value That Occurred in the 2018 Calendar Year

February 04, 2019

Simplify Aggregate Spend Compliance with an Internet-based Tracking and Reporting Solution

Request a Demo